Assessment of human radiation dose of metabotropic glutamate receptor type 1 ligand [C-11]ITMM PET/CT

Assessment of human radiation dose of metabotropic glutamate receptor type 1 ligand [C-11]ITMM PET/CT - Dosimetry of [C-11]ITMM PET/CT

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012396

Enrollment

Registered

2013-11-25

Start date

2013-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

The dosage in the vein of [C-11]ITMM for PET/CT imaging.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The subjects who has intention to participate in this study, and signed informed consent. 2. Male and female subjects of >=20 and <60 years, old. 3. The subject who was judged by clinical investigator by means of physical examination and laboratory tests to be eligible as a participant in this study.

Exclusion criteria

Exclusion criteria: 1.The subject who has dysfunction in the liver / kidney. 2.The subject who has abnormal findings in the central nervous system. 3.The subjects having cardiac failure. 4.The subject with a history of a drug or food allergy. 5.Tobacco smoker

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics, Dosimetry	—

Countries

Japan

Contacts

Public ContactIshii Kenji

Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

ishii@pet.tmig.or.jp03-3964-3241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026